Literature DB >> 6124699

Keratitis from high doses intravenous cytarabine.

M G Gressel, R L Tomsak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6124699     DOI： 10.1016/s0140-6736(82)90357-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis.

Authors:  C Samarawickrama; A S Ioannidis; A W Wechsler; S L Watson
Journal:  Leukemia       Date:  2013-08-13       Impact factor: 11.528

Review 2.  Ocular Adverse Events Associated with Antibody-Drug Conjugates in Human Clinical Trials.

Authors:  Joshua Seth Eaton; Paul E Miller; Mark J Mannis; Christopher J Murphy
Journal:  J Ocul Pharmacol Ther       Date:  2015-11-05       Impact factor: 2.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.